UBS Group’s Kyverna Therapeutics KYTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Sell |
98,158
-79,512
| -45% | -$244K | ﹤0.01% | 5225 |
|
|
2025
Q1 | $343K | Sell |
177,670
-25,733
| -13% | -$49.7K | ﹤0.01% | 4934 |
|
|
2024
Q4 | $761K | Buy |
203,403
+195,207
| +2,382% | +$730K | ﹤0.01% | 4422 |
|
|
2024
Q3 | $40.1K | Sell |
8,196
-1,448
| -15% | -$7.08K | ﹤0.01% | 5757 |
|
|
2024
Q2 | $72.3K | Sell |
9,644
-15,254
| -61% | -$114K | ﹤0.01% | 5259 |
|
|
2024
Q1 | $618K | Buy |
+24,898
| New | +$618K | ﹤0.01% | 3932 |
|